Ivacaftor
Showing 1 - 25 of 197
Elexacaftor/Tezacaftor/Ivacaftor, in Cystic Fibrosis and Caloric
Completed
- Cystic Fibrosis
- nutritional intake questionnaire
-
Bordeaux, France
- +2 more
Oct 2, 2023
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor
Enrolling by invitation
- Cystic Fibrosis
-
Denver, Colorado
- +1 more
Apr 7, 2023
CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -
Recruiting
- Cystic Fibrosis
- Elexacaftor / Ivacaftor / Tezacaftor
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Oct 7, 2022
Cystic Fibrosis (CF), CFTR Gene Mutation Trial (12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause)
Not yet recruiting
- Cystic Fibrosis (CF)
- CFTR Gene Mutation
- 12 hours ETI pause
- +2 more
- (no location specified)
Apr 17, 2023
Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet
Not yet recruiting
- Healthy Volunteer
- Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
- Lumacaftor 200 mg Film-Coated Tablet Formulation
- (no location specified)
Jul 21, 2023
Ivacaftor for Acquired CFTR Dysfunction in Chronic
Active, not recruiting
- CRS
- EDSPD
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 24, 2022
Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects
Completed
- Cystic Fibrosis
- Ivacaftor
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 10, 2022
Cystic Fibrosis Trial in Worldwide (ivacaftor)
Active, not recruiting
- Cystic Fibrosis
- ivacaftor
-
Birmingham, Alabama
- +22 more
Feb 4, 2022
Cystic Fibrosis Trial in Worldwide (Ivacaftor)
Active, not recruiting
- Cystic Fibrosis
- Ivacaftor
-
Birmingham, Alabama
- +28 more
Sep 14, 2022
Drug Drug Interaction Trial in Los Angeles (Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg], Rifabutin
Recruiting
- Drug Drug Interaction
- Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
- Rifabutin 300mg
-
Los Angeles, CaliforniaUniversity of Southern California
May 9, 2022
Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor
Completed
- Cystic Fibrosis
-
Paris, FranceAdult CF center, Service de Pneumologie, Cochin Hospital
Dec 20, 2021
COPD, Chronic Bronchitis Trial in Birmingham (Ivacaftor 150 MG, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Chronic Bronchitis
- Ivacaftor 150 MG
- Placebo
-
Birmingham, AlabamaUAB Lung Health Center
Mar 24, 2022
Respiratory Symptoms and Spirometry During ETI Treatment in
Active, not recruiting
- Cystic Fibrosis
- Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening
-
Liège, BelgiumLebecque
Oct 25, 2022
Cystic Fibrosis Trial in France (Sample collection)
Recruiting
- Cystic Fibrosis
- Sample collection
-
Bordeaux, France
- +14 more
Jul 7, 2023
Cystic Fibrosis Transmembrane Regulator Biomarker Study to
Recruiting
- Cystic Fibrosis
- Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor
-
Berlin, Germany
- +3 more
Apr 1, 2022
Chronic Bronchitis Trial in Birmingham (Ivacaftor (VX-770))
Withdrawn
- Chronic Bronchitis
- Ivacaftor (VX-770)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 1, 2022
Trikafta Exercise Study in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- Lung Diseases
-
Vancouver, British Columbia, CanadaUBC Centre for Heart Lung Innovation, St. Paul's Hospital
Mar 3, 2022
COPD Trial (Ivacaftor)
Withdrawn
- Chronic Obstructive Pulmonary Disease
- Ivacaftor
- (no location specified)
Jan 11, 2022
Cystic Fibrosis Trial in Birmingham (Symdeko)
Recruiting
- Cystic Fibrosis
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 30, 2022